Search published articles


Showing 1 results for Ziaolhagh

Fariba Rasannezhad , Asieh Abbassi Daloii, Javad Ziaolhagh , Ahmad Abdi ,
Volume 18, Issue 6 (Nov-Dec 2024)
Abstract

Background: The purpose of the present study was to investigate the effect of aerobic exercise and psilocybin after methamphetamine induction on the gene expression of certain cerebral cortex semaphorins in female Wistar rats.
Methods: In this experimental study, 40 female rats were placed into five groups: control (C), amphetamine (A), amphetamine-aerobic (AA), amphetamine-psilocybin (AP), and amphetamine-psilocybin-aerobic (AAP). Methamphetamine was injected at a dose of 15 mg/kg for 5 days in the morning. Psilocybin was administered at a dose of 1 mg/kg. The aerobic training program included running on a treadmill at 20–25 m/min, three days a week for eight weeks. After eight weeks, gene expression was measured using the Real-Time PCR method. The data were analyzed by one-way analysis of variance and Tukey's post hoc test at a significance level of P < 0.05.
Results: The results showed that the average gene expression of semaphorin 3A, semaphorin 4A, and semaphorin 7A in the cerebral cortex of the A group had a significant increase compared to the C group (P = 0.001). The AA, AP, and AAP groups showed a significant decrease in the average expression of semaphorin 3A and semaphorin 4A genes compared to the A group (P = 0.001). The AAP group had a significant decrease in the average expression of the semaphorin 3A gene compared to the AA and AP groups (P = 0.001). In addition, the AAP group showed a significant decrease in semaphorin 7A expression compared to the AP group (P = 0.007).
Conclusion: According to the results, aerobic training and psilocybin supplementation can help reduce semaphorin expression in the cerebral cortex of rats induced with methamphetamine.


Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.